Try a new search

Format these results:

Searched for:

in-biosketch:true

person:snudem01

Total Results:

479


PERIPHERAL BLOOD DNA METHYLATION PROFILES IDENTIFY IDH1/2 MUTATION STATUS IN ADULTS WITH DIFFUSE GLIOMA [Meeting Abstract]

Kloetgen, Andreas; Serrano, Jonathan; Patel, Seema; Bowman, Christopher; Shen, Guomiao; Zagzag, David; Karajannis, Matthias; Golfinos, John; Placantonakis, Dimitris; Tsirigos, Aristotelis; Chi, Andrew S; Snuderl, Matija
ISI:000415152501194
ISSN: 1523-5866
CID: 2802432

H3 K27M MUTANT GLIOMAS ARE SELECTIVELY KILLED BY ONC201, A SMALL MOLECULE INHIBITOR OF DOPAMINE RECEPTOR D2 [Meeting Abstract]

Chi, Andrew S; Stafford, James M; Sen, Namita; Possemato, Richard; Placantonakis, Dimitris; Hidalgo, Eveline Teresa; Harter, David; Wisoff, Jeffrey; Golfinos, John; Arrillaga-Romany, Isabel; Batchelor, Tracy; Wen, Patrick; Wakimoto, Hiroaki; Cahill, Daniel; Allen, Joshua E; Oster, Wolfgang; Snuderl, Matija
ISI:000415152501151
ISSN: 1523-5866
CID: 2802442

CHARACTERIZATION OF GPR133 EXPRESSION IN GLIOMA SUBTYPES [Meeting Abstract]

Kader, Michael; Frenster, Joshua; Liechty, Benjamin; Modrek, Aram; Tsirigos, Aristotelis; Golfinos, John; Eisele, Sylvia; Jain, Rajan; Shepherd, Timothy; Fatterpekar, Girish; MacNeil, Douglas; Shohdy, Nadim; Huang, Xinyan; Chi, Andrew S; Snuderl, Matija; Zagzag, David; Placantonakis, Dimitris
ISI:000415152500139
ISSN: 1523-5866
CID: 2802482

A PHASE II, OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY OF AVELUMAB WITH HYPOFRACTIONATED RE-IRRADIATION IN ADULT SUBJECTS WITH TRANSFORMED IDH MUTANT GLIOBLASTOMA [Meeting Abstract]

Chi, Andrew S; Eisele, Sylvia; Arrillaga-Romany, Isabel; Batchelor, Tracy; Cahill, Daniel; Taylor, Jennie; Cloughesy, Timothy F; Patel, Amie; Delara, Malcolm; Latchman, Sunita; Placantonakis, Dimitris; Pacione, Donato; Fatterpekar, Girish; Shepherd, Timothy; Jain, Rajan; Cordova, Christine; Schafrick, Jessica; Snuderl, Matija; Zagzag, David; Kondziolka, Douglas; Golfinos, John; Silverman, Joshua
ISI:000415152500099
ISSN: 1523-5866
CID: 2802502

A DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas [Meeting Abstract]

Wu, P; Cooper, B; Bu, F; Bowman, C; Jonathan, K; Serrano, J; Wang, S; Jackson, T; Gorovets, D; Gorlick, R; Ladanyi, M; Thomas, K; Snuderl, M; Karajannis, M
ISI:000408978202292
ISSN: 1545-5017
CID: 2766962

A DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas [Meeting Abstract]

Cooper, BT; Wu, SP; Bu, F; Bowman, CJ; Killian, JK; Serrano, J; Wang, S; Gorovets, D; Gorlick, RG; Ladanyi, M; Thomas, K; Snuderl, M; Karajannis, MA
ISI:000411559104225
ISSN: 1879-355x
CID: 2766742

Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2

Modrek, Aram S; Golub, Danielle; Khan, Themasap; Bready, Devin; Prado, Jod; Bowman, Christopher; Deng, Jingjing; Zhang, Guoan; Rocha, Pedro P; Raviram, Ramya; Lazaris, Charalampos; Stafford, James M; LeRoy, Gary; Kader, Michael; Dhaliwal, Joravar; Bayin, N Sumru; Frenster, Joshua D; Serrano, Jonathan; Chiriboga, Luis; Baitalmal, Rabaa; Nanjangud, Gouri; Chi, Andrew S; Golfinos, John G; Wang, Jing; Karajannis, Matthias A; Bonneau, Richard A; Reinberg, Danny; Tsirigos, Aristotelis; Zagzag, David; Snuderl, Matija; Skok, Jane A; Neubert, Thomas A; Placantonakis, Dimitris G
Low-grade astrocytomas (LGAs) carry neomorphic mutations in isocitrate dehydrogenase (IDH) concurrently with P53 and ATRX loss. To model LGA formation, we introduced R132H IDH1, P53 shRNA, and ATRX shRNA into human neural stem cells (NSCs). These oncogenic hits blocked NSC differentiation, increased invasiveness in vivo, and led to a DNA methylation and transcriptional profile resembling IDH1 mutant human LGAs. The differentiation block was caused by transcriptional silencing of the transcription factor SOX2 secondary to disassociation of its promoter from a putative enhancer. This occurred because of reduced binding of the chromatin organizer CTCF to its DNA motifs and disrupted chromatin looping. Our human model of IDH mutant LGA formation implicates impaired NSC differentiation because of repression of SOX2 as an early driver of gliomagenesis.
PMCID:5687844
PMID: 29091765
ISSN: 2211-1247
CID: 2758982

Osimertinib Dose Escalation Induces Regression of Progressive EGFR T790M-Mutant Leptomeningeal Lung Adenocarcinoma [Letter]

Cordova, Christine; Chi, Andrew S; Chachoua, Abraham; Kondziolka, Douglas; Silverman, Joshua S; Shepherd, Timothy M; Jain, Rajan; Snuderl, Matija
PMID: 29074213
ISSN: 1556-1380
CID: 2756442

A cerebellar window for intravital imaging of normal and disease states in mice

Askoxylakis, Vasileios; Badeaux, Mark; Roberge, Sylvie; Batista, Ana; Kirkpatrick, Ned; Snuderl, Matija; Amoozgar, Zohreh; Seano, Giorgio; Ferraro, Gino B; Chatterjee, Sampurna; Xu, Lei; Fukumura, Dai; Duda, Dan G; Jain, Rakesh K
The cerebellum is a prominent part of the vertebrate hindbrain that is critically involved in the regulation of important body functions such as movement coordination, maintenance of balance and posture, and motor control. Here, we describe a cerebellar window that provides access to the mouse cerebellum for intravital imaging, thereby allowing for a detailed characterization of the dynamic processes in this region of the brain. First, the skull overlying the cerebellum is removed, and then the window is applied to the region of interest. Windows may be exchanged depending on the desired imaging modality. This technique has a variety of applications. In the setting of medulloblastoma, spontaneous or orthotopically implanted lesions can be imaged, and tumor morphology and size can be monitored using ultrasonography. Multiphoton laser-scanning microscopy (MPLSM) or optical-frequency-domain imaging (OFDI) can be applied for in vivo visualization and analysis of cellular and vascular structures in a variety of disease states, including malignancies and ataxia telangiectasia. This protocol describes a novel and rapid method for cerebellar window construction that can be set up in under an hour.
PMCID:5918134
PMID: 28981123
ISSN: 1750-2799
CID: 2719592

Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients

Blazer, Ashira; Wang, Binhuan; Simpson, Danny; Kirchhoff, Tomas; Heffron, Sean; Clancy, Robert M; Heguy, Adriana; Ray, Karina; Snuderl, Matija; Buyon, Jill P
OBJECTIVE: Atherosclerosis is exaggerated in African American (AA) systemic lupus erythematosus (SLE) patients, with doubled cardiovascular disease (CVD) risk compared to White patients. The extent to which common Apolipoprotein L1 (APOL1) risk alleles (RA) contribute to this trend is unknown. This retrospective cohort study assessed prevalent atherosclerotic disease across APOL1 genotypes in AA SLE patients. METHODS: One hundred thirteen AA SLE subjects were APOL1-genotyped and stratified as having: zero risk alleles, one risk allele, or two risk alleles. Chart review assessed CVD manifestations including abdominal aortic aneurysm, angina, carotid artery disease, coronary artery disease, myocardial infarction, peripheral vascular disease, stroke, and vascular calcifications. Associations between the genotypes and a composite endpoint defined as one or more CVD manifestations were calculated using logistic regression. Symptomatic atherosclerotic disease, excluding incidental vascular calcifications, was also assessed. RESULTS: The 0-risk-allele, 1-risk-allele and 2-risk-allele groups, respectively, comprised 34%, 53%, and 13% of the cohort. Respectively, 13.2%, 41.7%, and 60.0% of the 0-risk allele, 1-risk-allele, and 2-risk-allele groups met the composite endpoint of atherosclerotic CVD (p = 0.001). Adjusting for risk factors-including smoking, ESRD, BMI >25 and hypertension-we observed an association between carrying one or more RA and atherosclerotic CVD (OR = 7.1; p = 0.002). For symptomatic disease, the OR was 3.5 (p = 0.02). In a time-to-event analysis, the proportion of subjects free from the composite primary endpoint, symptomatic atherosclerotic CVD, was higher in the 0-risk-allele group compared to the 1-risk-allele and 2-risk-allele groups (chi2 = 6.5; p = 0.04). CONCLUSIONS: Taken together, the APOL1 RAs associate with prevalent atherosclerotic CVD in this cohort of AA SLE patients, perhaps reflecting a potentiating effect of SLE on APOL1-related cardiovascular phenotypes.
PMCID:5574561
PMID: 28850570
ISSN: 1932-6203
CID: 2679052